𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chronic genotype 4 hepatitis C

✍ Scribed by Daniel F. Schafer


Book ID
102239398
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
63 KB
Volume
47
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


My colleagues and I read with great interest the article by Livraghi et al., where the authors stated that radiofrequency ablation (RFA) could be considered the treatment of choice for patients with a singe hepatocellular carcinoma Υ… 2 cm, even when surgical treatment is possible. 1 We agree with the main conclusion of the authors. As the authors have pointed out, RFA seems to be equivalent to surgery in terms of local disease control and survival. 1 In addition, RFA is generally much less invasive than surgery and is associated with a lower complication rate. 2 It is no longer unusual that RFA can be the treatment of choice for patients with a single small hepatocellular carcinoma nodule. The investigators must be congratulated for their difficult work.

However, we have a question concerning the statistical analysis. In the study, multivariate analysis demonstrated that the appearance of one or more new lesions was the only statistically significant factor. However, the appearance of any new lesion is a delayed phenomenon after RFA. We think that prognosis prediction based on a delayed phenomenon would be of little value in treatment planning and survival prediction at the initial stage of interventional management. We would like to know the results of multivariate analysis after exclusion of this factor. After the exclusion, other factors such as operability might become statistically significant as determined by multivariate analysis.


πŸ“œ SIMILAR VOLUMES


Pegylated interferon and ribavirin thera
✍ F. Legrand-Abravanel; F. Nicot; A. Boulestin; K. Sandres-SaunΓ©; J.P. Vinel; L. A πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 91 KB

## Abstract Hepatitis C Virus (HCV) is classified into six genotypes. Genotype 4 is now spreading in Europe, especially among drug users, who are often infected with both HCV and the human immunodeficiency virus (HIV). Previous studies have shown that HCV‐4 responds poorly to interferon. Pegylated

Response to pegylated interferon alfa-2a
✍ Hesham El Makhzangy; Gamal Esmat; Mohamed Said; Maissa ElRaziky; Soheir Shouman; πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 91 KB

## Abstract The safety and efficacy of pegylated interferon (PEG‐IFN) alfa‐2a and ribavirin were studied among patients treated for genotype 4 chronic hepatitis C. Ninety‐five patients with chronic hepatitis C genotype 4 were treated with PEG‐IFN alfa‐2a (180 ¡g/week) plus ribavirin (β‰₯11 mg/kg/day)